Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Weight In Gold - Madison — Peptide Therapy in Madison, WI

Weight In Gold - Madison Peptides & Treatments Nearby Clinics Madison, WI About Weight In Gold in Madison, Wisconsin operates as a physician-led obesity medicine practice under the direction of Dr. Leslie Golden, a board-certified MD credentialed by the Americ

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Weight In Gold - Madison

Peptides & Treatments

Nearby Clinics

Madison, WI

About

Weight In Gold in Madison, Wisconsin operates as a physician-led obesity medicine practice under the direction of Dr. Leslie Golden, a board-certified MD credentialed by the American Board of Obesity Medicine. The clinic holds designation as an American Diabetes Association Certified Diabetes Center, reflecting its structured protocols for managing both obesity and metabolic disease within a single treatment framework. Dr. Golden's practice integrates pharmacotherapy, nutrition intervention, and behavioral modification rather than treating weight as an isolated metric, addressing the physiological drivers of obesity and type 2 diabetes through evidence-based protocols tailored to each patient's metabolic profile.

The clinic's pharmacotherapy program centers on three GLP-1 receptor agonists: liraglutide, semaglutide, and tirzepatide. Liraglutide is often introduced for patients requiring once-daily dosing or those with cardiovascular risk factors, given its FDA approval for reducing major adverse cardiac events. Semaglutide, available in both subcutaneous and oral formulations, is utilized for patients seeking once-weekly administration and demonstrated efficacy in clinical trials showing average weight reduction of 15-17% of body weight. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is reserved for patients with obesity and comorbid type 2 diabetes or those who have not achieved target outcomes with single-agonist therapy. Dr. Golden titrates these medications based on tolerance, glycemic response, and weight trajectory, adjusting dosing schedules and combinations according to individual patient data rather than applying uniform protocols.

Dr. Leslie Golden completed her medical degree and residency training before pursuing additional certification in obesity medicine, a subspecialty requiring examination by the American Board of Obesity Medicine and ongoing CME in metabolic disease management. Her clinical approach treats obesity as a chronic disease with genetic, hormonal, and environmental components, rather than a lifestyle failure. Patients undergo comprehensive metabolic assessment including HbA1c, fasting insulin, lipid panels, and thyroid function before initiating GLP-1 therapy. The clinic's nutrition therapy component is delivered by registered dietitians who create individualized meal frameworks based on patients' cultural preferences, work schedules, and metabolic needs, rather than prescribing standardized calorie targets. Behavioral coaching addresses the psychological patterns surrounding food intake, stress eating, and long-term habit formation, with sessions structured to identify specific triggers and develop concrete coping strategies.

Patients at Weight In Gold begin with an initial consultation that includes a full medical history review, physical examination, and laboratory workup to assess candidacy for GLP-1 therapy and identify contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Follow-up visits occur every two to four weeks during the titration phase, then transition to monthly or quarterly monitoring once patients reach maintenance dosing. The clinic tracks not only weight and BMI but also waist circumference, blood pressure, fasting glucose, and patient-reported outcomes including energy levels, sleep quality, and medication side effects. Patients receive direct communication access to the clinical team for questions about dosing adjustments, managing gastrointestinal side effects, or navigating insurance prior authorization processes. The Madison clinic operates with both in-person appointments at its Wisconsin location and telehealth consultations for patients throughout Wisconsin, allowing continued care for patients who relocate within the state or prefer remote monitoring.

Weight In Gold differentiates itself through its dual certification in obesity medicine and diabetes care, enabling Dr. Golden to manage the full spectrum of metabolic disease without requiring patients to coordinate care across multiple specialists. The clinic does not promote rapid weight loss timelines or guarantee specific outcomes, instead emphasizing sustainable metabolic improvement and long-term disease management. Patients with type 2 diabetes often see reductions in HbA1c alongside weight loss, sometimes allowing for deprescribing of other glucose-lowering medications under physician supervision. The practice accepts insurance for medical visits and works with patients to navigate coverage for GLP-1 medications, which vary significantly by payer and plan type. For Wisconsin residents seeking physician-supervised obesity treatment with access to the latest incretin-based therapies, Weight In Gold provides a medically rigorous alternative to commercial weight loss programs, grounded in the pathophysiology of metabolic disease rather than caloric restriction alone.

Care Team

Dr. Leslie Golden· Board-Certified MD

Our Team

Leslie Golden, MD, MPH, DABOM

Founder and Obesity Medicine Physician

Dr. Leslie Golden is a board-certified specialist in family medicine and obesity medicine, dedicated to providing compassionate care and eliminating the stigma associated with obesity.

Vikram Goyal, MD, DABOM

Obesity Medicine Physician

Dr. Vikram Goyal is a board-certified obesity medicine physician focused on helping patients achieve their weight health goals.

Natalie Ross, DNP, FNP-BC, APNP

Nurse Practitioner

Natalie Ross is a nurse practitioner specializing in obesity medicine and chronic disease management.

Katie Zahour, MS, MSN, ANP-BC

Katie Zahour is a nurse practitioner with a focus on obesity and weight management.

Jessica Krupinski, PA-C

Physician Assistant

Jessica Krupinski is a physician assistant specializing in obesity medicine.

Caitlin Rondello, MS, RD, CDCES

Registered Dietitian

Caitlin Rondello is a registered dietitian and certified diabetes care and education specialist.

Patient Reviews

Services Offered

Obesity Medication Management

Evidence-based medical treatments to assist in obesity management.

Diabetes Management

Personalized plans for blood sugar control and lifestyle guidance.

Medical Nutrition Therapy

Personalized nutrition plans developed by registered dietitians.

Behavioral and Lifestyle Coaching

Coaching to help patients understand habits and create systems for change.

Fitness Coaching and Body Composition Analysis

Personalized fitness plans based on body composition analysis.

Virtual Health Services

Online consultations and follow-ups for convenient care.

FAQ

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What if I travel frequently? Can I continue peptide therapy?

Most injectable peptides travel reasonably well with proper handling. Your clinic should provide guidance on traveling with peptides, including storage requirements and TSA considerations. Understanding peptide stability at room temperature helps plan for travel situations.

Source: seekpeptides.com ↗
comparison

Inflammation reduction versus fat reduction: which matters more?

This is the question that the Italian exenatide study highlighted so powerfully. Case 1 lost no weight but still experienced pain reduction and measurable changes in subcutaneous fat thickn…

Source: seekpeptides.com
comparison

Keto supplements versus GLP-1 medications: they are not the same thing

This distinction requires absolute clarity because confusion here can be dangerous. Exogenous ketone supplements, MCT oil products, and "keto pills" sold over the counter are NOT GLP-1 rece…

Source: seekpeptides.com
Research context

Read sources and limitations before applying a claim.

Peptide Therapy: What Doctors Actually Prescribe vs. What's Being Marketed Without Evidence

Reviewed by Yoshinori Abe, MD Internal Medicine Only a few peptides are FDA-approved and prescribed by licensed physicians, each backed by rigorous clinical trials: Teriparatide and abaloparatide — treat osteoporosis Bremelanotide — treats low sexual desire IGF-1 — treats rare growth disorders GLP-1 agonists (semaglutide, tirzepatide) — treat type 2 diabetes and support weight management Many other peptides sold online make bold claims but lack human clinical data, standardized dosing, and verified safety profiles. Approved uses, off-label risks, and legal concerns all matter when weighing your options. Unsure whether peptide therapy fits your symptoms or health goals? Before pursuing unverified products or booking appointments, take a free, instant, online symptom check to identify what may actually be driving your concerns. In just minutes, you'll receive evidence-based guidance on smart next steps — whether that's a proven peptide, an alternative treatment, or a focused conversation with your doctor — so you can avoid wasted time, money, and risk. Reviewed for medical accuracy: 06/17/2026

Source: ubiehealth.com ↗

Real-World Applications and Research Focus in 2026

By 2026, the potential applications for Wolverine Stack combined peptide therapy in research have expanded considerably beyond initial expectations. We're seeing intense interest in its role within Muscle Building Research, where protocols are being explored for accelerating recovery post-exertion, enhancing lean muscle accrual, and improving overall physical adaptation. This is particularly relevant for studies involving tissue remodeling and strength development. Furthermore, the longevity research space is keenly observing the potential of Wolverine Stack combined peptide therapy. Given that many of its components influence growth hormone, cellular repair, and inflammatory responses, there's a burgeoning area of inquiry into how these stacks might impact markers of aging and overall cellular resilience. Researchers are actively looking at compounds like Epithalon or Pinealon within broader Longevity Research frameworks, often integrated with the core concepts of the Wolverine Stack to explore comprehensive anti-aging paradigms. Our commitment to providing research-grade peptides means we're constantly updating our offerings to reflect these evolving trends. When researchers seek to replicate or expand upon groundbreaking studies involving Wolverine Stack combined peptide therapy, they need components they can trust implicitly. That's what we deliver. We understand the demanding schedules and high expectations of modern research, and we're here to support every step of the way.

Source: realpeptides.co ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

CJC 1295 Protocols, Dosages and Administration

CJC 1295 is a legal drug approved by the FDA and is only available through prescription. Once your naturopathic doctor determines that you will benefit from this peptide, he/she will give you a prescription. This peptide is administered subcutaneously (under the skin) in the stomach or abdomen. The dosage will vary with your needs, and the doctor may prescribe a daily or days on days off dose. The best time to take CJC 1295 is in the evening to allow it to mimic the body’s natural production of the growth hormone, which mainly takes place at night.

Source: livvnatural.com ↗
Potential benefits

16 Mar Can Autoimmune Conditions Benefit from Peptide Therapy?

Peptide therapy may benefit individuals with autoimmune conditions by supporting immune function and reducing inflammation. Certain peptides work on T-cells to help the immune system operate efficiently, while others possess anti-inflammatory properties that can alleviate symptoms.1 Additionally, peptide therapy promotes tissue repair by stimulating collagen production, which can be vital for managing tissue damage caused by autoimmune conditions.2

Source: conciergemdla.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →